Posted by Michael Wonder on 01 Apr 2019
Breast cancer and rare skin cancer medicines on the PBS
1 April 2019 - The Liberal National Government is improving the lives of patients with breast cancer and a rare skin cancer by subsidising innovative medicines on the PBS, saving patients up to $150,000 a year.
The Liberal National Government is improving the lives of patients with breast cancer and a rare skin cancer by subsidising innovative medicines on the Pharmaceutical Benefits Scheme (PBS), saving patients up to $150,000 a year.
In this year’s Budget our Government will invest $81.5 million to list the medicine Bavencio (avelumab) on the PBS for the first time for the treatment of metastatic merkel cell carcinoma, a rare and highly aggressive type of skin cancer.
